Elite Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Elite Pharmaceuticals with three other
pharmaceutical manufacturers in North America:
sales of 20.44 million Canadian Dollars [US$16.02 million]
(6.21 million Canadian Dollars [US$4.86 million]
Organovo Holdings Incorporated
of which 100%
was Developing and Commercializing Human Tis).
During the year ended March of 2017, sales at
Elite Pharmaceuticals were $9.64 million.
decrease of 22.9%
versus 2016, when the company's sales were $12.50 million.